In contrast to the promotive effects of PCDH7 in breast and lung cancer, downregulated PCDH7 correlates with advanced grade, larger tumor size, and poorer overall survival in bladder cancer and gastric cancer patients (Lin et al., 2016; Chen et al., 2017). This evidence concerns the gene PCDH7 and lung cancer.